We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Vortioxetine

Vortioxetine |CAS NO: 508233-74-7 is an antidepressant medication used primarily to treat major depressive disorder (MDD) in adults. It’s classified as a serotonin modulator and stimulator. Serotonin Reuptake Inhibition: It inhibits the reuptake of serotonin, making more serotonin available in the brain. Serotonin Receptor Modulation: It acts on various serotonin receptors, which can help improve mood and cognitive function. Vortioxetine is known for its potential benefits in reducing depressive symptoms and improving cognitive function, and it may have a somewhat different side effect profile compared to other antidepressants.

 

We are the Synchemia Research Chemical specializes in manufacturing and supplying of Vortioxetine impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Vortioxetine is a medication with a variety of medicinal uses, Serotonin Reuptake Inhibition: It inhibits the reuptake of serotonin, making more serotonin available in the brain. Serotonin Receptor Modulation: It acts on various serotonin receptors, which can help improve mood and cognitive function we the Synchemia are ensuring the purity and quality of its impurities which is crucial for pharmaceutical API manufacturing companies for regulatory compliance. Buy Reliable and High-Purity Vortioxetine Impurities, Delivered by Synchemia Research Chemicals.

 

download image Download catalogue

Pharmaceutical Reference Standards

Vortioxetine Impurity 31
Vortioxetine Impurity 31
CAT No SRC-V22267
CAS No 13616-82-5
Mol.F. C8H10S
Mol.Wt. 138.2 g/mol
INV STATUS CUSTOM SYNTHESIS
Vortioxetine Impurity 32
Vortioxetine Impurity 32
CAT No SRC-V22268
CAS No 1610527-49-5
Mol.F. C14H13NO2S
Mol.Wt. 259.3 g/mol
INV STATUS CUSTOM SYNTHESIS
Despiperazine Vortioxetine
Despiperazine Vortioxetine
CAT No SRC-V22269
CAS No 1019453-85-0
Mol.F. C14H15NS
Mol.Wt. 229.3 g/mol
INV STATUS IN STOCK
Para-Vortioxetine Hydrobromide
Para-Vortioxetine Hydrobromide
CAT No SRC-V22270
CAS No NA
Mol.F. C18H22N2S : HBr
Mol.Wt. 298.4 : 80.9 g/mol
INV STATUS CUSTOM SYNTHESIS
Vortioxetine Bromo Impurity (HCl salt)
Vortioxetine Bromo Impurity (HCl salt)
CAT No SRC-V22271
CAS No NA
Mol.F. C18H21BrN2S : HCl
Mol.Wt. 377.3 : 36.5 g/mol
INV STATUS CUSTOM SYNTHESIS
Vortioxetine Disulfane Impurity
Vortioxetine Disulfane Impurity
CAT No SRC-V22272
CAS No 103-19-5
Mol.F. C14H14S2
Mol.Wt. 246.4 g/mol
INV STATUS CUSTOM SYNTHESIS
Para Vortioxetine Impurity
Para Vortioxetine Impurity
CAT No SRC-V22273
CAS No 1815608-51-5
Mol.F. C18H22N2S
Mol.Wt. 298.4 g/mol
INV STATUS UNDER SYNTHESIS
Vortioxetine Impurity 53
Vortioxetine Impurity 53
CAT No SRC-V22274
CAS No NA
Mol.F. C18H21BrN2S
Mol.Wt. 377.3 g/mol
INV STATUS CUSTOM SYNTHESIS
Vortioxetine Impurity 59
Vortioxetine Impurity 59
CAT No SRC-V22275
CAS No 1019364-34-1
Mol.F. C14H15NS
Mol.Wt. 229.3 g/mol
INV STATUS CUSTOM SYNTHESIS
Vortioxetine Impurity 37
Vortioxetine Impurity 37
CAT No SRC-V22276
CAS No NA
Mol.F. C40H51N5S2
Mol.Wt. 666.0 g/mol
INV STATUS CUSTOM SYNTHESIS
Vortioxetine Sulfone
Vortioxetine Sulfone
CAT No SRC-V22277
CAS No 1639263-80-1
Mol.F. C18H22N2O2S
Mol.Wt. 330.5 g/mol
INV STATUS IN STOCK

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.